Benjamin Edwards Inc’s VanEck Pharmaceutical ETF PPH Stock Holding History

Benjamin Edwards Inc’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-21	Closed	-$1K	–	299
2019 Q3	$1K	Hold	21	–	–	﹤0.01%	292
2019 Q2	$1K	Buy	+21	New	+$1.22K	﹤0.01%	297

Other funds holding PPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Benjamin Edwards Inc's PPH Position: Q4 2019 in Review

Benjamin Edwards Inc sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2019, closing a stake of 21 shares — an estimated $1K sold.

Benjamin Edwards Inc first reported a position in PPH in Q2 2019 and held it in 2 quarters. The position peaked at $1K in Q3 2019. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2019.

Benjamin Edwards Inc reported no remaining VanEck Pharmaceutical ETF position as of Q4 2019 after selling out during the quarter.
Benjamin Edwards Inc sold 21 VanEck Pharmaceutical ETF shares in Q4 2019, an estimated $1K.
Benjamin Edwards Inc first reported a position in VanEck Pharmaceutical ETF in Q2 2019 and held it in 2 quarters.
Benjamin Edwards Inc's VanEck Pharmaceutical ETF position peaked at $1K in Q3 2019.
49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2019.

Based on Benjamin Edwards Inc's 13F filing for Q4 2019, filed 6 Feb 2020.